This highly productive, fast-growing biotech is led by physician-scientists (not businesspeople), and its employees are inspired by a sense of “endless possibilities.” Those vast opportunities are professional as well as scientific. The drugmaker has created a path for research associates to work their way up to the rank of scientist—rather than having to slave away for a Ph.D.—and it encourages collaboration across the company through popular “lab warmings,” firm-wide networking events where teams showcase their work.
Read Great Place to Work review here.
Looking for leads, investment insights, or competitive intelligence?
News about Regeneron Pharmaceuticals
Amgen says Repatha sold $271 million in the first half of 2018, despite earlier predictions of multi-billion-dollar sales.
Scientists are ready to move an experimental treatment into phase 1 trials.
“We should only be working on two things, health and the freaking environment.”
But Dupixent's high cost could be a problem.